15-27990627-C-T

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1

The NM_000275.3(OCA2):​c.1065G>A​(p.Ala355Ala) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.717 in 1,613,344 control chromosomes in the GnomAD database, including 438,294 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.59 ( 31157 hom., cov: 33)
Exomes 𝑓: 0.73 ( 407137 hom. )

Consequence

OCA2
NM_000275.3 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:7

Conservation

PhyloP100: -1.25

Publications

69 publications found
Variant links:
Genes affected
OCA2 (HGNC:8101): (OCA2 melanosomal transmembrane protein) This gene encodes the human homolog of the mouse p (pink-eyed dilution) gene. The encoded protein is believed to be an integral membrane protein involved in small molecule transport, specifically tyrosine, which is a precursor to melanin synthesis. It is involved in mammalian pigmentation, where it may control skin color variation and act as a determinant of brown or blue eye color. Mutations in this gene result in type 2 oculocutaneous albinism. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jul 2014]
OCA2 Gene-Disease associations (from GenCC):
  • oculocutaneous albinism type 2
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Orphanet, Ambry Genetics, G2P, ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.52).
BP6
Variant 15-27990627-C-T is Benign according to our data. Variant chr15-27990627-C-T is described in ClinVar as Benign. ClinVar VariationId is 255716.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-1.25 with no splicing effect.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.789 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
OCA2NM_000275.3 linkc.1065G>A p.Ala355Ala synonymous_variant Exon 10 of 24 ENST00000354638.8 NP_000266.2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
OCA2ENST00000354638.8 linkc.1065G>A p.Ala355Ala synonymous_variant Exon 10 of 24 1 NM_000275.3 ENSP00000346659.3
OCA2ENST00000353809.9 linkc.1045-961G>A intron_variant Intron 9 of 22 1 ENSP00000261276.8

Frequencies

GnomAD3 genomes
AF:
0.586
AC:
89073
AN:
151998
Hom.:
31163
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.215
Gnomad AMI
AF:
0.770
Gnomad AMR
AF:
0.571
Gnomad ASJ
AF:
0.715
Gnomad EAS
AF:
0.400
Gnomad SAS
AF:
0.363
Gnomad FIN
AF:
0.839
Gnomad MID
AF:
0.753
Gnomad NFE
AF:
0.794
Gnomad OTH
AF:
0.629
GnomAD2 exomes
AF:
0.639
AC:
160311
AN:
251022
AF XY:
0.640
show subpopulations
Gnomad AFR exome
AF:
0.203
Gnomad AMR exome
AF:
0.536
Gnomad ASJ exome
AF:
0.706
Gnomad EAS exome
AF:
0.382
Gnomad FIN exome
AF:
0.829
Gnomad NFE exome
AF:
0.798
Gnomad OTH exome
AF:
0.701
GnomAD4 exome
AF:
0.731
AC:
1068472
AN:
1461228
Hom.:
407137
Cov.:
48
AF XY:
0.723
AC XY:
525916
AN XY:
726944
show subpopulations
African (AFR)
AF:
0.191
AC:
6404
AN:
33470
American (AMR)
AF:
0.542
AC:
24241
AN:
44718
Ashkenazi Jewish (ASJ)
AF:
0.706
AC:
18449
AN:
26130
East Asian (EAS)
AF:
0.403
AC:
15982
AN:
39690
South Asian (SAS)
AF:
0.392
AC:
33804
AN:
86234
European-Finnish (FIN)
AF:
0.830
AC:
44179
AN:
53246
Middle Eastern (MID)
AF:
0.671
AC:
3870
AN:
5768
European-Non Finnish (NFE)
AF:
0.791
AC:
879785
AN:
1111600
Other (OTH)
AF:
0.692
AC:
41758
AN:
60372
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.460
Heterozygous variant carriers
0
14576
29152
43728
58304
72880
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
20228
40456
60684
80912
101140
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.586
AC:
89067
AN:
152116
Hom.:
31157
Cov.:
33
AF XY:
0.583
AC XY:
43375
AN XY:
74388
show subpopulations
African (AFR)
AF:
0.215
AC:
8920
AN:
41486
American (AMR)
AF:
0.570
AC:
8710
AN:
15278
Ashkenazi Jewish (ASJ)
AF:
0.715
AC:
2482
AN:
3470
East Asian (EAS)
AF:
0.399
AC:
2052
AN:
5142
South Asian (SAS)
AF:
0.363
AC:
1749
AN:
4818
European-Finnish (FIN)
AF:
0.839
AC:
8892
AN:
10600
Middle Eastern (MID)
AF:
0.762
AC:
224
AN:
294
European-Non Finnish (NFE)
AF:
0.794
AC:
54016
AN:
68000
Other (OTH)
AF:
0.624
AC:
1320
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.506
Heterozygous variant carriers
0
1400
2800
4200
5600
7000
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
698
1396
2094
2792
3490
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.708
Hom.:
63156
Bravo
AF:
0.557
Asia WGS
AF:
0.432
AC:
1506
AN:
3478
EpiCase
AF:
0.783
EpiControl
AF:
0.780

ClinVar

Significance: Benign
Submissions summary: Benign:7
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:3
Jun 20, 2025
Women's Health and Genetics/Laboratory Corporation of America, LabCorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Sep 17, 2015
Eurofins Ntd Llc (ga)
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Tyrosinase-positive oculocutaneous albinism Benign:2
Sep 05, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

not provided Benign:2
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.52
CADD
Benign
0.35
DANN
Benign
0.52
PhyloP100
-1.2
Mutation Taster
=91/9
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs1800404; hg19: chr15-28235773; COSMIC: COSV62338507; API